Lista de obras - Fernando Antoñanzas - Dominio Público Uruguay

Alcohol consumption in the EU: health economics and policy issues under a permanent debate.

artículo científico publicado en 2008

Análisis coste-efectividad en la evaluación económica de intervenciones sanitarias

Análisis de costes y resultados en la evaluación económica de las intervenciones sanitarias

Budget impact analysis of a pneumococcal vaccination programme in the 65-year-old Spanish cohort using a dynamic model

artículo científico publicado en 2013

Challenges to achieving value in drug spending in a decentralized country: the Spanish case

artículo científico publicado en 2003

Channeling health economics research initiatives to improve decision-making processes in the EU

scientific article published on 11 April 2013

Coping with uncertainty on health decisions: assessing new solutions

artículo científico publicado en 2012

Core discrete event simulation model for the evaluation of health care technologies in major depressive disorder

artículo científico publicado en 2014

Cost Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccination Program in Chronic Obstructive Pulmonary Disease Patients Aged 50+ Years in Spain

artículo científico publicado en 2015

Cost effectiveness of hepatitis A virus immunisation in Spain

artículo científico publicado en 1997

Cost-effectiveness analysis of hepatitis B vaccination strategies in Catalonia, Spain

artículo científico publicado en 1995

Cost-effectiveness analysis of levobupivacaine 0.5 %, a local anesthetic, infusion in the surgical wound after modified radical mastectomy.

artículo científico publicado en 2015

Cost-effectiveness analysis of samario-153 (Quadramet) for the treatment of patients with prostate cancer and bone metastases

artículo científico publicado en 2005

Cost-effectiveness of memantine in community-based Alzheimer's disease patients: An adaptation in Spain.

artículo científico publicado en 2006

Cost-effectiveness of tapentadol in severe chronic pain in Spain: a cost analysis of data from RCTs

artículo científico publicado en 2012

Defining and Measuring the Affordability of New Medicines: A Systematic Review

artículo científico publicado en 2017

Dynamic modelling of infectious diseases: an application to the economic evaluation of influenza vaccination

artículo científico publicado en 2008

Economic analysis of health technologies and programmes. A Spanish proposal for methodological standardisation

artículo científico publicado en 1995

Economic aspects of the new Spanish laws on pharmaceutical preparations.

artículo científico publicado en 2007

Economic evaluation and decision-making in health. The role of economic evaluation in the adoption and spread of health technologies. 2008 SESPAS Report

scientific article published on 01 April 2008

Economic evaluation of personalized medicine: a call for real-world data

artículo científico publicado en 2017

Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis

artículo científico publicado en 2002

Economic evaluations in the EURONHEED: a comparative analysis

artículo científico publicado en 2009

Economic features of antibiotic resistance: the case of methicillin-resistant Staphylococcus aureus.

artículo científico publicado en 2015

Efficient health research and improving Europeans' health

artículo científico publicado en 2015

Feeding the economics of obesity in the EU in a healthy way

artículo científico publicado en 2010

Healthy vs. unhealthy food: a strategic choice for firms and consumers.

artículo científico publicado en 2011

Hepatitis B management costs in France, Italy, Spain, and the United Kingdom

artículo científico publicado en 2004

Hospital care for persons with AIDS in the European Union.

artículo científico publicado en 1997

Implementation of risk-sharing contracts as perceived by Spanish hospital pharmacists

artículo científico publicado en 2019

Implementing personalized medicine with asymmetric information on prevalence rates

scientific article published on December 2015

Improving health care systems by building 'more Europe'

artículo científico publicado en 2016

Information disclosure and smoking risk perceptions. Potential short-term impact on Spanish students of the new European Union directive on tobacco products

artículo científico publicado en 2002

Is personalized medicine a panacea for health management? Some thoughts on its desirability

scientific article published on 01 June 2015

New prescription for the Spanish drug sector: fighting against public deficit without wasting ammunition

scientific article published on 01 January 2010

Non safety costs in the Spanish health care system

artículo científico publicado en 2013

On vaccination programs in the EU Member States: the case of the human papilloma virus

artículo científico publicado en 2016

Personalized Medicine and Pay for Performance: Should Pharmaceutical Firms be Fully Penalized when Treatment Fails?

artículo científico publicado en 2018

Pharmaceutical costs of assisted reproduction in Spain

artículo científico publicado en 2013

Pharmaceutical patents, R&D incentives and access to new drugs: new ways of progress at the crossroad

artículo científico publicado en 2011

Postoperative analgesia by infusion of local anesthetic into the surgical wound after modified radical mastectomy: a randomized clinical trial

artículo científico publicado en 2014

Se hace camino al andar

scientific article published on 01 January 2010

Should health authorities offer risk-sharing contracts to pharmaceutical firms? A theoretical approach.

artículo científico publicado en 2011

Should the patent system for pharmaceuticals be replaced? A theoretical approach

artículo científico publicado en 2014

Some economics on personalized and predictive medicine

artículo científico publicado en 2014

Spanish recommendations on economic evaluation of health technologies

artículo científico publicado en 2010

The Use of Risk-Sharing Contracts in Healthcare: Theoretical and Empirical Assessments

artículo científico publicado en 2019

The Value of Medicines: A Crucial but Vague Concept

artículo científico publicado en 2016

The impact of the economic downturn on healthcare in Spain: consequences and alternatives.

artículo científico

The social cost of illegal drug consumption in Spain.

artículo científico publicado en 2002

Tobacco policies in the European Union: a need for state and continental harmonisation?

artículo científico publicado en 2007

Transferability indices for health economic evaluations: methods and applications.

artículo científico publicado en 2009

Transferability of economic evaluation results

artículo científico publicado en 2004

Vaccination against hepatitis B virus in Spain: a cost-effectiveness analysis

artículo científico publicado en 1997

[A proposed guideline for economic evaluation of health technologies]

artículo científico publicado en 2009

[Alcoholic beverages in Spain: health and economics]

scientific article published on 01 May 2008

[Comment. On studies of the costs of healthcare processes]

scientific article published on 01 September 2006

[Cost-effectiveness of the combination therapy of dutasteride and tamsulosin in the treatment of benign prostatic hyperlasia in Spain]

artículo científico publicado en 2011

[Economic drug evaluation: experiences and pathways to progress]

artículo científico publicado en 2008

[Economic evaluation studies in health]

scientific article published on 01 December 2005

[Economic impact of the taxus coronary stent: implications for the Spanish healthcare system]

artículo científico publicado en 2006

[Equity and variability in the use of medical technologies]

artículo científico publicado en 2006

[On decision rules, cost-effectiveness, and budget impact]

artículo científico publicado en 2008

[Prioritization of health interventions according to their effectiveness: an intermediate step in the road towards a more efficient medicine]

artículo científico publicado en 2012

[Probabilistic Markov models in economic evaluation of health technologies: a practical guide]

artículo científico publicado en 2010

[Use of a retail sales tax on tobacco to fund drug therapy for smoking cessation]

artículo científico publicado en 2006

Lista de obras de Fernando Antoñanzas

Alcohol consumption in the EU: health economics and policy issues under a permanent debate.

Análisis coste-efectividad en la evaluación económica de intervenciones sanitarias

Análisis de costes y resultados en la evaluación económica de las intervenciones sanitarias

Budget impact analysis of a pneumococcal vaccination programme in the 65-year-old Spanish cohort using a dynamic model

Challenges to achieving value in drug spending in a decentralized country: the Spanish case

Channeling health economics research initiatives to improve decision-making processes in the EU

Coping with uncertainty on health decisions: assessing new solutions

Core discrete event simulation model for the evaluation of health care technologies in major depressive disorder

Cost Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccination Program in Chronic Obstructive Pulmonary Disease Patients Aged 50+ Years in Spain

Cost effectiveness of hepatitis A virus immunisation in Spain

Cost-effectiveness analysis of hepatitis B vaccination strategies in Catalonia, Spain

Cost-effectiveness analysis of levobupivacaine 0.5 %, a local anesthetic, infusion in the surgical wound after modified radical mastectomy.

Cost-effectiveness analysis of samario-153 (Quadramet) for the treatment of patients with prostate cancer and bone metastases

Cost-effectiveness of memantine in community-based Alzheimer's disease patients: An adaptation in Spain.

Cost-effectiveness of tapentadol in severe chronic pain in Spain: a cost analysis of data from RCTs

Defining and Measuring the Affordability of New Medicines: A Systematic Review

Dynamic modelling of infectious diseases: an application to the economic evaluation of influenza vaccination

Economic analysis of health technologies and programmes. A Spanish proposal for methodological standardisation

Economic aspects of the new Spanish laws on pharmaceutical preparations.

Economic evaluation and decision-making in health. The role of economic evaluation in the adoption and spread of health technologies. 2008 SESPAS Report

Economic evaluation of personalized medicine: a call for real-world data

Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis

Economic evaluations in the EURONHEED: a comparative analysis

Economic features of antibiotic resistance: the case of methicillin-resistant Staphylococcus aureus.

Efficient health research and improving Europeans' health

Feeding the economics of obesity in the EU in a healthy way

Healthy vs. unhealthy food: a strategic choice for firms and consumers.

Hepatitis B management costs in France, Italy, Spain, and the United Kingdom

Hospital care for persons with AIDS in the European Union.

Implementation of risk-sharing contracts as perceived by Spanish hospital pharmacists

Implementing personalized medicine with asymmetric information on prevalence rates

Improving health care systems by building 'more Europe'

Information disclosure and smoking risk perceptions. Potential short-term impact on Spanish students of the new European Union directive on tobacco products

Is personalized medicine a panacea for health management? Some thoughts on its desirability

New prescription for the Spanish drug sector: fighting against public deficit without wasting ammunition

Non safety costs in the Spanish health care system

On vaccination programs in the EU Member States: the case of the human papilloma virus

Personalized Medicine and Pay for Performance: Should Pharmaceutical Firms be Fully Penalized when Treatment Fails?

Pharmaceutical costs of assisted reproduction in Spain

Pharmaceutical patents, R&D incentives and access to new drugs: new ways of progress at the crossroad

Postoperative analgesia by infusion of local anesthetic into the surgical wound after modified radical mastectomy: a randomized clinical trial

Se hace camino al andar

Should health authorities offer risk-sharing contracts to pharmaceutical firms? A theoretical approach.

Should the patent system for pharmaceuticals be replaced? A theoretical approach

Some economics on personalized and predictive medicine

Spanish recommendations on economic evaluation of health technologies

The Use of Risk-Sharing Contracts in Healthcare: Theoretical and Empirical Assessments

The Value of Medicines: A Crucial but Vague Concept

The impact of the economic downturn on healthcare in Spain: consequences and alternatives.

The social cost of illegal drug consumption in Spain.

Tobacco policies in the European Union: a need for state and continental harmonisation?

Transferability indices for health economic evaluations: methods and applications.

Transferability of economic evaluation results

Vaccination against hepatitis B virus in Spain: a cost-effectiveness analysis

[A proposed guideline for economic evaluation of health technologies]

[Alcoholic beverages in Spain: health and economics]

[Comment. On studies of the costs of healthcare processes]

[Cost-effectiveness of the combination therapy of dutasteride and tamsulosin in the treatment of benign prostatic hyperlasia in Spain]

[Economic drug evaluation: experiences and pathways to progress]

[Economic evaluation studies in health]

[Economic impact of the taxus coronary stent: implications for the Spanish healthcare system]

[Equity and variability in the use of medical technologies]

[On decision rules, cost-effectiveness, and budget impact]

[Prioritization of health interventions according to their effectiveness: an intermediate step in the road towards a more efficient medicine]

[Probabilistic Markov models in economic evaluation of health technologies: a practical guide]

[Use of a retail sales tax on tobacco to fund drug therapy for smoking cessation]